Progressive acute kidney injury following myocardial infarction: cholesterol embolisation
- PMID: 21686929
- PMCID: PMC3028520
- DOI: 10.1136/bcr.06.2008.0103
Progressive acute kidney injury following myocardial infarction: cholesterol embolisation
Abstract
Acute kidney injury following acute coronary event can occur from multiple factors, including secondary to volume depletion, poor perfusion because of cardiac dysfunction, secondary to medications such as angiotensin converting enzyme inhibitors or angiotensin receptor blockers or because of aggressive diuretics or use of contrast agents. Atheroembolism (cholesterol embolisation) often occurs following an intervention, such as angiography or revascularisation procedure. An uncommon presentation of atheroembolic renal disease that likely was precipitated by the use of thrombolytics and/or anticoagulation is discussed.
Figures
References
-
- Modi KS, Rao VK. Atheroembolic renal disease. J Am Soc Nephrol 2001; 12: 1871–87 - PubMed
-
- Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 2003; 42: 211–6 - PubMed
-
- Blakenship JC, Butler M, Garbes A. prospective assessment of cholesterol embolization in patients with acute myocardial infarction treated with thrombolytic vs conservative therapy. Chest 1995; 107: 662–8 - PubMed
-
- Moolenaar W, Lamers CB. Cholesterol crystal embolization in the Netherlands. Arch Intern Med 1996; 156: 653–7 - PubMed
LinkOut - more resources
Full Text Sources